mRNA |
Repligen 136 |
CTRPv2 |
pan-cancer |
AAC |
0.019 |
0.6 |
mRNA |
trifluoperazine |
CTRPv2 |
pan-cancer |
AAC |
-0.02 |
0.6 |
mRNA |
fluvastatin |
CTRPv2 |
pan-cancer |
AAC |
-0.019 |
0.6 |
mRNA |
canertinib |
CTRPv2 |
pan-cancer |
AAC |
-0.019 |
0.6 |
mRNA |
navitoclax:birinapant (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.019 |
0.6 |
mRNA |
ATRA |
FIMM |
pan-cancer |
AAC |
0.088 |
0.6 |
mRNA |
JQ-1:MK-0752 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.017 |
0.6 |
mRNA |
CIL56 |
CTRPv2 |
pan-cancer |
AAC |
-0.023 |
0.6 |
mRNA |
Topotecan |
FIMM |
pan-cancer |
AAC |
0.06 |
0.6 |
mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
-0.016 |
0.6 |